EBS vs. NVDA
Compare and contrast key facts about Emergent BioSolutions Inc. (EBS) and NVIDIA Corporation (NVDA).
Performance
EBS vs. NVDA - Performance Comparison
Loading graphics...
EBS vs. NVDA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
EBS Emergent BioSolutions Inc. | -32.20% | 29.29% | 298.33% | -79.68% | -72.83% | -51.48% | 66.08% | -8.99% | 27.57% | 41.50% |
NVDA NVIDIA Corporation | -5.76% | 38.92% | 171.25% | 239.02% | -50.26% | 125.48% | 122.30% | 76.94% | -30.82% | 81.99% |
Fundamentals
EBS:
$475.15M
NVDA:
$4.29T
EBS:
$0.94
NVDA:
$4.90
EBS:
8.89
NVDA:
35.88
EBS:
0.11
NVDA:
0.20
EBS:
0.63
NVDA:
19.95
EBS:
0.91
NVDA:
27.30
EBS:
$742.90M
NVDA:
$215.94B
EBS:
$0.00
NVDA:
$153.46B
EBS:
$271.60M
NVDA:
$144.55B
Returns By Period
In the year-to-date period, EBS achieves a -32.20% return, which is significantly lower than NVDA's -5.76% return. Over the past 10 years, EBS has underperformed NVDA with an annualized return of -13.20%, while NVDA has yielded a comparatively higher 69.75% annualized return.
EBS
- 1D
- 0.96%
- 1M
- -6.79%
- YTD
- -32.20%
- 6M
- -8.81%
- 1Y
- 76.79%
- 3Y*
- -6.83%
- 5Y*
- -36.39%
- 10Y*
- -13.20%
NVDA
- 1D
- 0.77%
- 1M
- -3.68%
- YTD
- -5.76%
- 6M
- -6.13%
- 1Y
- 59.59%
- 3Y*
- 85.01%
- 5Y*
- 66.40%
- 10Y*
- 69.75%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
EBS vs. NVDA — Risk / Return Rank
EBS
NVDA
EBS vs. NVDA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Emergent BioSolutions Inc. (EBS) and NVIDIA Corporation (NVDA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| EBS | NVDA | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.83 | 1.45 | -0.62 |
Sortino ratioReturn per unit of downside risk | 1.94 | 2.14 | -0.20 |
Omega ratioGain probability vs. loss probability | 1.26 | 1.27 | -0.01 |
Calmar ratioReturn relative to maximum drawdown | 1.69 | 3.08 | -1.39 |
Martin ratioReturn relative to average drawdown | 4.27 | 7.73 | -3.45 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| EBS | NVDA | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.83 | 1.45 | -0.62 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.36 | 1.29 | -1.65 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.17 | 1.40 | -1.57 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.02 | 0.61 | -0.64 |
Correlation
The correlation between EBS and NVDA is 0.26, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
EBS vs. NVDA - Dividend Comparison
EBS has not paid dividends to shareholders, while NVDA's dividend yield for the trailing twelve months is around 0.02%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EBS Emergent BioSolutions Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 5.65% | 0.00% |
NVDA NVIDIA Corporation | 0.02% | 0.02% | 0.03% | 0.03% | 0.11% | 0.05% | 0.12% | 0.27% | 0.46% | 0.29% | 0.45% | 1.20% |
Drawdowns
EBS vs. NVDA - Drawdown Comparison
The maximum EBS drawdown since its inception was -98.89%, which is greater than NVDA's maximum drawdown of -89.72%. Use the drawdown chart below to compare losses from any high point for EBS and NVDA.
Loading graphics...
Drawdown Indicators
| EBS | NVDA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.89% | -89.72% | -9.17% |
Max Drawdown (1Y)Largest decline over 1 year | -42.95% | -20.21% | -22.74% |
Max Drawdown (5Y)Largest decline over 5 years | -98.14% | -66.34% | -31.80% |
Max Drawdown (10Y)Largest decline over 10 years | -98.89% | -66.34% | -32.55% |
Current DrawdownCurrent decline from peak | -93.79% | -15.10% | -78.69% |
Average DrawdownAverage peak-to-trough decline | -40.60% | -36.40% | -4.20% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 16.95% | 8.05% | +8.90% |
Volatility
EBS vs. NVDA - Volatility Comparison
The current volatility for Emergent BioSolutions Inc. (EBS) is 9.05%, while NVIDIA Corporation (NVDA) has a volatility of 10.43%. This indicates that EBS experiences smaller price fluctuations and is considered to be less risky than NVDA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| EBS | NVDA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.05% | 10.43% | -1.38% |
Volatility (6M)Calculated over the trailing 6-month period | 61.33% | 25.79% | +35.54% |
Volatility (1Y)Calculated over the trailing 1-year period | 93.41% | 41.42% | +51.99% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 102.08% | 51.72% | +50.36% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 79.69% | 49.84% | +29.85% |
Financials
EBS vs. NVDA - Financials Comparison
This section allows you to compare key financial metrics between Emergent BioSolutions Inc. and NVIDIA Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities